Global Biosimilar Markets: Europe vs United States
Europe led the world in biosimilars since 2006, building a mature market with strong adoption. The U.S. lagged due to legal and regulatory hurdles, but recent FDA changes are accelerating growth. Both regions now face a $200B+ opportunity as biologics lose patent protection.
Read More
